NOL6 and endometrial cancer: Other RiBi factors might be of interest as biomarker of efficacy, including NOL6, the human homologous of a yeast snoRNA‐associated protein complex involved in rRNA maturation that has been shown to promote proliferative and migration capacities of endometrial cancer cells [28].